<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ojrdrt</journal-id><journal-title-group><journal-title xml:lang="ru">Онкологический журнал: лучевая диагностика, лучевая терапия</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of oncology: diagnostic radiology and radiotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7593</issn><issn pub-type="epub">2713-167X</issn><publisher><publisher-name>НЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37174/2587-7593-2018-1-3-10-14</article-id><article-id custom-type="elpub" pub-id-type="custom">ojrdrt-11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЯДЕРНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NUCLEAR MEDICINE</subject></subj-group></article-categories><title-group><article-title>Производство радиофармацевтического лекарственного средства 18F-фтордезоксиглюкоза</article-title><trans-title-group xml:lang="en"><trans-title>Production of Radiopharmaceutical Medicinal Product 18F-Fluorodeoxyglucose</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Невзоров</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Nevzorov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скрипачев</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Skripachev</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">i.skripachev@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгушин</surname><given-names>М. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgushin</surname><given-names>M. B.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Оджарова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Odzharova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремин</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremin</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2018</year></pub-date><volume>1</volume><issue>3</issue><fpage>10</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Невзоров Д.И., Скрипачев И.А., Долгушин М.Б., Оджарова А.А., Еремин Н.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Невзоров Д.И., Скрипачев И.А., Долгушин М.Б., Оджарова А.А., Еремин Н.В.</copyright-holder><copyright-holder xml:lang="en">Nevzorov D.I., Skripachev I.A., Dolgushin M.B., Odzharova A.A., Eremin N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.oncoradjournal.ru/jour/article/view/11">https://www.oncoradjournal.ru/jour/article/view/11</self-uri><abstract><p>В работе рассмотрен современный коммерческий способ производства самого востребованного в онкологии радиофармацевтического диагностического лекарственного средства 18F-фтордезоксиглюкозы (2-фтор-18F-2-дезокси-D-глюкоза, 18F-ФДГ), представлены технологические стадии и операции синтеза, процедуры контроля качества, кратко описаны требования, предъявляемые к упаковке и маркировке данного радиофармацевтического препарата.</p></abstract><trans-abstract xml:lang="en"><p>In the article considers modern commercial method of production is demanded used in oncology medical product radiopharmaceutical 18F-fluorodeoxyglucose (2-fluoro-18F-2-deoxy-D-glucose, 18F-FDG), are presented the process steps and operation of synthesis, quality control procedures, briefly described the requirements for packaging and labeling of radiopharmaceutical.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>18F-фтордезоксиглюкоза</kwd><kwd>синтез</kwd><kwd>радиофармацевтический препарат</kwd><kwd>РФП</kwd><kwd>позитронная эмиссионная тоМография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>18F-fluorodeoxyglucose</kwd><kwd>synthesis</kwd><kwd>radiopharmaceutical</kwd><kwd>positron emission tomography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kam Leung. 2005. [18F]Fluoro-2-deoxy-2-D-glucose in Molecular Imaging and Contrast Agent Database (MICAD). National Center for Biotechnology Information, NLM, NIH, Bethesda, MD.</mixed-citation><mixed-citation xml:lang="en">Kam Leung. 2005. [18F]Fluoro-2-deoxy-2-D-glucose in Molecular Imaging and Contrast Agent Database (MICAD). National Center for Biotechnology Information, NLM, NIH, Bethesda, MD.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zanoni L., Al-Sugair A.S., Fanti S. Clinical applications of 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography-computed tomography (PET/CT) // Nucl. Med. Rev. 2012. Vol. 15. Suppl. P. C48–C51.</mixed-citation><mixed-citation xml:lang="en">Zanoni L., Al-Sugair A.S., Fanti S. Clinical applications of 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography-computed tomography (PET/CT) // Nucl. Med. Rev. 2012. Vol. 15. Suppl. P. C48–C51.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Тулин П. Е., Долгушин М. Б., Патютко И. Ю. и соавт. ПЭТ/КТ с 18F-ФДГ и 18F-холином в диагностике смешанного гепатохолангиоцеллюлярного рака (клиническое наблюдение) // Диагн. и интервенц. радиол. 2015. Т. 9. № 1. C. 91–99.</mixed-citation><mixed-citation xml:lang="en">Тулин П. Е., Долгушин М. Б., Патютко И. Ю. и соавт. ПЭТ/КТ с 18F-ФДГ и 18F-холином в диагностике смешанного гепатохолангиоцеллюлярного рака (клиническое наблюдение) // Диагн. и интервенц. радиол. 2015. Т. 9. № 1. C. 91–99.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Min-Fu Yang, Diwakar Jain, Zuo-Xiang He. 18F-FDG cardiac studies for identifying ischemic memory // Curr. Cardiovasc. Imaging Rep. 2012. Vol. 5. P. 383–389.</mixed-citation><mixed-citation xml:lang="en">Min-Fu Yang, Diwakar Jain, Zuo-Xiang He. 18F-FDG cardiac studies for identifying ischemic memory // Curr. Cardiovasc. Imaging Rep. 2012. Vol. 5. P. 383–389.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ghesani M., Depuey E.G., Rozanski A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability // Echocardiography. 2005. Vol. 22. № 2. P. 165–177.</mixed-citation><mixed-citation xml:lang="en">Ghesani M., Depuey E.G., Rozanski A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability // Echocardiography. 2005. Vol. 22. № 2. P. 165–177.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nose H., Otsuka H., Otomi Y. et al. Evaluation of normal physiologic left ventricular myocardial 18F-FDG uptake at fasting state // Europ. Congress of Radiol. 1-5 March, 2012. Vienna, Austria. URL: http://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&amp;doi=10.1594/ecr2012/C-11922012.</mixed-citation><mixed-citation xml:lang="en">Nose H., Otsuka H., Otomi Y. et al. Evaluation of normal physiologic left ventricular myocardial 18F-FDG uptake at fasting state // Europ. Congress of Radiol. 1-5 March, 2012. Vienna, Austria. URL: http://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&amp;doi=10.1594/ecr2012/C-11922012.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dong Soo Lee, Sang Kun Lee, Myung Chul Lee. Functional neuroimaging in epilepsy: FDG PET and Ictal SPECT // Korean Medю Sci. 2001. Vol. 16. P. 689–696.</mixed-citation><mixed-citation xml:lang="en">Dong Soo Lee, Sang Kun Lee, Myung Chul Lee. Functional neuroimaging in epilepsy: FDG PET and Ictal SPECT // Korean Medю Sci. 2001. Vol. 16. P. 689–696.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Teune L.K., Bartels A.L., Leenders K.L. FDG-PET Imaging in neurodegenerative brain diseases // In: Functional Brain Mapping and the Endeavor to Understand the Working Brain. Ed. by F. Signorelli and D. Chirchiglia. 2013.</mixed-citation><mixed-citation xml:lang="en">Teune L.K., Bartels A.L., Leenders K.L. FDG-PET Imaging in neurodegenerative brain diseases // In: Functional Brain Mapping and the Endeavor to Understand the Working Brain. Ed. by F. Signorelli and D. Chirchiglia. 2013.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez-Catasus C.A., Vallez Garcia D., Le Riverend Morales E., Galvizu S.R. Traumatic brain injury // In: Nuclear Medicine Neuroimaging. PET and SPECT in Neurology, 2014. P. 923–946.</mixed-citation><mixed-citation xml:lang="en">Sanchez-Catasus C.A., Vallez Garcia D., Le Riverend Morales E., Galvizu S.R. Traumatic brain injury // In: Nuclear Medicine Neuroimaging. PET and SPECT in Neurology, 2014. P. 923–946.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Masangkay N., Basu S., Moghbel M. et al. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings // Nucl. Med. Commun. 2014. Vol. 35. № 10. P. 1038–1046.</mixed-citation><mixed-citation xml:lang="en">Masangkay N., Basu S., Moghbel M. et al. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings // Nucl. Med. Commun. 2014. Vol. 35. № 10. P. 1038–1046.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jones S.C., Alavi A., Christman D. et al. The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man // J. Nucl. Med. 1982. Vol. 23. P. 613–617.</mixed-citation><mixed-citation xml:lang="en">Jones S.C., Alavi A., Christman D. et al. The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man // J. Nucl. Med. 1982. Vol. 23. P. 613–617.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ido T., Wan C.N., Fowler J.S. Fluorination with F2: convenient synthesis of 2-deoxy-2-fluoro-d-glucose // J. Org. Chem. 1977. Vol. 42. P. 2341–2342.</mixed-citation><mixed-citation xml:lang="en">Ido T., Wan C.N., Fowler J.S. Fluorination with F2: convenient synthesis of 2-deoxy-2-fluoro-d-glucose // J. Org. Chem. 1977. Vol. 42. P. 2341–2342.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution // J. Nucl. Med. 1986. Vol. 27. P. 235–238.</mixed-citation><mixed-citation xml:lang="en">Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution // J. Nucl. Med. 1986. Vol. 27. P. 235–238.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Toorongian S.A., Mulholland G.K., Jewett D.M. et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin // Int. J. Rad. Appl. Instrum. B. 1990. Vol. 17. № 3. P. 273–279.</mixed-citation><mixed-citation xml:lang="en">Toorongian S.A., Mulholland G.K., Jewett D.M. et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin // Int. J. Rad. Appl. Instrum. B. 1990. Vol. 17. № 3. P. 273–279.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">СанПиН 2.6.1.3288-15. Гигиенические требования по обеспечению радиационной безопасности при подготовке и проведении позитронной эмиссионной томографии.</mixed-citation><mixed-citation xml:lang="en">СанПиН 2.6.1.3288-15. Гигиенические требования по обеспечению радиационной безопасности при подготовке и проведении позитронной эмиссионной томографии.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gomzina N.A., Vasil’ev D.A., Krasikova R.N. Optimization of automated synthesis of 2-[18F]Fluoro-2-deoxy-D-glucose involving base hydrolysis // Radiochemistry. 2002. Vol. 44. № 4. P. 403–409.</mixed-citation><mixed-citation xml:lang="en">Gomzina N.A., Vasil’ev D.A., Krasikova R.N. Optimization of automated synthesis of 2-[18F]Fluoro-2-deoxy-D-glucose involving base hydrolysis // Radiochemistry. 2002. Vol. 44. № 4. P. 403–409.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gopal B. Saha. Basics of PET Imaging: Physics, Chemistry and Regulations. 3th ed. – New York: Springer International Publishing. 2016. 165 pp.</mixed-citation><mixed-citation xml:lang="en">Gopal B. Saha. Basics of PET Imaging: Physics, Chemistry and Regulations. 3th ed. – New York: Springer International Publishing. 2016. 165 pp.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
